Brands: Durezol · Difluprednate
Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Sandoz Inc | generic | 1 | SUPPLYING |
| Upsher-Smith Laboratories, LLC | unknown | 1 | SUPPLYING |
| Caplin Steriles Limited | unknown | 1 | SUPPLYING |
| Cipla USA Inc. | generic | 1 | SUPPLYING |
| Leading Pharma, LLC | unknown | 1 | SUPPLYING |
| Mylan Pharmaceuticals Inc. | generic | 1 | EXITED 2027 |
Shortages, recalls, and registration changes attached to this drug concept.
Lack of Assurance of Sterility: customer complaint for defective container where breakage of the protective cap exposes tip of eye drop which could compromise sterility. — Recalling firm: CIPLA — Nationwide in the USA
Lack of Assurance of Sterility: Complaints received of defective container closure. — Recalling firm: CIPLA — Nationwide in the USA
Lack of Assurance of Sterility: customer complaint for defective container where breakage of the protective cap exposes tip of eye drop which could compromise sterility. — Recalling firm: CIPLA — Nationwide in the USA
